Basic Information
Valitor is an antibody-drug conjugate (ADC) developer. The company's lead program, VLTR-557, is a highly engineered anti-VEGF antibody conjugate designed to overcome the limitations of established drug targets through multivalent biopolymer technology, thereby maximizing benefits for patients.
Valitor, Inc
California,United States of America
less than 15 people
January 01, 2010
info@valitorbio.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios